451 people die in Pennsylvania with COVID-19 listed as the underlying cause in week ending October 23

451 people die in Pennsylvania with COVID-19 listed as the underlying cause in week ending October 23
0Comments

There were 451 deaths with COVID-19 listed as the underlying cause reported in Pennsylvania during the week ending October 23, a 5.6 percent decrease from the previous week, according to The Centers for Disease Control and Prevention.

In the week ending October 23, there were 3,000 deaths in the state. 20 percent of deaths were caused by heart disease, 16.9 percent were from cancer and 31.5 percent were from COVID-19. Additionally, 7.6 percent of deaths were from Alzheimer’s disease and dementia.

Studies show doctors and medical examiners may underreport Alzheimer’s disease and dementia-related conditions as the underlying cause of death on death certificates, according to the National Institute on Aging.

Once infected, older adults with dementia are likely to develop a more severe and dangerous illness. The diseases which make an older adult more vulnerable to COVID-19 are age-associated chronic conditions, according to the Bright Focus Foundation.

Pennsylvania top 10 causes of death in week ending October 23
Cause of Death Number of Deaths 2021-10-23 Number of Deaths 2021-10-16
Heart disease 601 573
Malignant neoplasms (cancerous tumor) 506 518
COVID-19 (multiple cause) 494 512
COVID-19 (underlying cause) 451 478
Cerebrovascular diseases 109 127
Chronic lower respiratory diseases 97 133
Alzheimer’s disease 81 76
Diabetes mellitus 80 67
Nephritis, nephrotic syndrome and nephrosis 57 57
Influenza and pneumonia 43 39
Pennsylvania Dementia deaths in week ending October 23
Cause of Death Number of Deaths 2021-10-23 Number of Deaths 2021-10-16
Alzheimer disease and dementia 229 222


Related

David G. Argall, Pennsylvania State Senator from 29th District

Stehr and Argall announce nearly $800,000 grant for Schuylkill County manufacturer

Keystone Potato Products will receive nearly $800,000 for clean energy upgrades at its Schuylkill County facility under Pennsylvania’s RISE PA program. Lawmakers say this investment supports job growth while reducing emissions.

Melanie Keller, Deputy Commissioner for Operations and Chief Operating Officer of FDA

FDA carried out the second most inspections of biologics companies in Pennsylvania in March

In March, the U.S. Food and Drug Administration (FDA) carried out inspections at six biologics firms located in Pennsylvania.

David G. Argall, Pennsylvania State Senator from 29th District

Twardzik and Argall announce state grant for manufacturing upgrades in West Mahanoy Township

MBA Building Supplies will receive over half a million dollars from the RISE PA program for facility upgrades aimed at increasing efficiency in West Mahanoy Township. Rep. Tim Twardzik and Sen. Dave Argall say these investments will help keep regional manufacturing competitive.